A Study in People With Colorectal Cancer to Test Whether Ezabenlimab or Pembrolizumab in Combination With BI 765063 Lead to Side Effects or Delays in Surgery
Clinical trial NCT05446129 · TERMINATED
Trial details
- NCT number
- NCT05446129
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-27
- Primary completion
- 2023-08-11
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.